K. Kamata et al., MECHANISMS OF DESENSITIZATION OF VASODILATATION INDUCED BY PLATELET-ACTIVATING-FACTOR IN HYPERTENSIVE RATS, European journal of pharmacology, 301(1-3), 1996, pp. 121-128
We found that vasodilator effects of platelet-activating factor (PAF)
on the mesenteric arterial bed of the rat were significantly attenuate
d in spontaneously hypertensive rats (SHR) and renal hypertensive rats
(RHR). Perfusion of the mesentery with acetylcholine and PAF caused e
ndothelium-dependent vasodilatation accompanied by an increase in cycl
ic GMP levels in the mesentery from normotensive Wistar Kyoto rats (WK
Y). Acetylcholine caused a significant increase in cyclic GMP levels i
n the effluent in both SHR and RHR, whereas PAF could not increase cyc
lic GMP levels in SHR and slightly increased cyclic GMP in RHR. Incuba
ting the mesentery with PAF markedly inhibited the vasodilatation indu
ced by PAF, but not acetylcholine or sodium nitroprusside. The cyclic
GMP accumulation in the effluent was impaired in the mesenteric arteri
al bed pretreated with PAF and in that obtained from rats given islet-
activating protein (IAP). The PAF-induced vasodilatation was completel
y reversed by the PAF receptor antagonist, CV-6209 -oxypropoxycarbonyl
)aminomethyl]-1-ethylpyridinium chloride). These results suggest that
(1) attenuated vasodilator effects of PAF and decreased cyclic GMP lev
els in the mesentery from SHR and RHR are due to desensitization but n
ot to impairment of the endothelium; (2) GTP-binding protein, which is
IAP-sensitive, may be involved in PAF-induced vasodilatation and cycl
ic GMP accumulation; (3) desensitization of the mesentery to PAF in SH
R and RHR may be due to PAF receptor and GTP-binding protein uncouplin
g.